“…23 The immunologic component in the mld-SZ diabetic model is highlighted by the absence of diabetes development in T-cell-deficient mice and by the protective effects of immunosuppressive or anti-inflammatory compounds 4,9,22,24,25 or vaccination with modified autoreactive lymphocytes. 5,6 It has been shown that mld-SZ administration depresses some constituents of the immune system, such as CD4 + T cells and some T-cell reactions, whereas macrophage activity and nonspecific cytotoxicity and production of interferon-g are activated. 26,27 Immune responses regulated by local cytokines may contribute to the diabetic state induced by mld-SZ because reduction and up-regulation of T H 2-type cytokines were, respectively, associated with susceptibility and resistance to mld-STZ-induced diabetes.…”